Cargando…
Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides
Peptide-based nanoparticles (PBN) for nucleotide complexation and targeting of extrahepatic diseases are gaining recognition as potent pharmaceutical vehicles for fine-tuned control of protein production (up- and/or down-regulation) and for gene delivery. Herein, we review the principles and mechani...
Autores principales: | Wickline, Samuel A., Hou, Kirk K., Pan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253970/ https://www.ncbi.nlm.nih.gov/pubmed/37298407 http://dx.doi.org/10.3390/ijms24119455 |
Ejemplares similares
-
Induction of WNT16 via Peptide-mRNA Nanoparticle-Based Delivery Maintains Cartilage Homeostasis
por: Yan, Huimin, et al.
Publicado: (2020) -
Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery
por: Boisguérin, Prisca, et al.
Publicado: (2021) -
Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery
por: Pan, Dipanjan, et al.
Publicado: (2016) -
Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
por: Strand, Matthew S., et al.
Publicado: (2019) -
Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015)